9QD-54200-93082
2 vaccinations
4 coded responses
15 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 983 / WA
- Registered
- 2021-11-16
- Relationship
- Self
- Race
- White
- Ethnicity
- N/A
Registered dependents
58L-54130-65601
Child or adolescent in my care · Male · 2021-11-16
WAP-22118-20249
Child or adolescent in my care · Male · 2021-11-16
VCJ-12144-77026
Child or adolescent in my care · Male · 2021-11-16
Timeline
-
2021-11-02
Dose 1 — Pfizer-BioNTech
-
2021-11-16
Registered in v-safe
- 2021-11-19
-
2021-11-23
Dose 2 — Pfizer-BioNTech
- 2021-11-24
- 2021-11-25
- 2021-11-26
- 2021-11-27
- 2021-11-28
- 2021-11-29
- 2021-11-30
-
2021-12-07
Survey response — day 14, dose 2MedDRA: Aphonia, Nasopharyngitis — Feeling: PoorFree text: Lost voice, cold symptomsMedDRA releases: 2024-11 · check-in free text available
- 2021-12-14
-
2021-12-26
Survey response — day 28, dose 2MedDRA: Lacrimation increased, Rhinorrhoea — Feeling: FairFree text: Runny nose, watery eyesMedDRA releases: 2024-11 · check-in free text available
- 2021-12-28
- 2022-01-04
-
2022-02-22
Survey response — 3 months, dose 2MedDRA: Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: PregnantMedDRA releases: 2024-11 · check-in free text available
-
2022-02-22
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-02-24
-
2022-05-29
Survey response — 6 months, dose 2MedDRA: Pregnancy — Feeling: GoodFree text: PregnantMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-02 | Pfizer-BioNTech | No |
| 2 | 2021-11-23 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 10 — day 14, dose 2
Symptoms: Lost voice, cold symptoms
Release 10 — day 28, dose 2
Symptoms: Runny nose, watery eyes
Release 11 — 3 months, dose 2
Symptoms: Pregnant
Release 11 — 6 months, dose 2
Symptoms: Pregnant
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Aphonia | · | · | ✓ |
| SD | Lacrimation increased | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release